Login
$CYRX
$19.80 -$0.09 (0.45%) Live

$CYRX SEC Filings

Filed On Filing
16 Nov 2026 SCHEDULE 13G/A
12 Nov 2026 Form 4: Sawicki Mark W, Chief Scientific Officer

Sold 10,000 shares ($199K)

12 Nov 2026 Form 4: Hancock Daniel M, Director

Received 74,379 shares by exercise or conversion ($737K) · Sold 74,379 shares ($1.5M)

10 Nov 2026 144
09 Nov 2026 144
05 Nov 2026 10-Q
05 Nov 2026 8-K: Results of Operations and Financial Condition

Third quarter revenue grew 14% year-over-year to $50.2 million

14 Aug 2026 SCHEDULE 13G/A
13 Aug 2026 SCHEDULE 13G/A
11 Aug 2026 Form 4: Shelton Jerrell, Director

Sold 28,800 shares ($429K)

11 Aug 2026 144
06 Aug 2026 10-Q
06 Aug 2026 8-K: Results of Operations and Financial Condition

Second quarter revenue grew 8% year-over-year to $49.0 million

29 Jul 2026 SCHEDULE 13G/A
22 Jun 2026 FORM S-8
22 Jun 2026 15-12G
12 Jun 2026 Form 4: Zecchini Edward J, Chief Digital and Tech Officer

Received 1,400 shares by exercise or conversion ($6.72K) · Sold 1,400 shares ($21.3K) · Received 33,600 shares by exercise or conversion ($161K) · 1 more

11 Jun 2026 144
10 Jun 2026 144
09 Jun 2026 8-K: Submission of Matters to a Vote of Security Holders

(as amended by the First Amendment (effective February 25, 2021), the Second Amendment (effective April 30, 2021), the Third Amendment (effective May 17, 2024), and the Fourth Amendment (effective June 5, 2026))

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support